World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
68
Citations
17007
World Ranking
7772
National Ranking
570

Martin Müller publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Martin Müller sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 277 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Martin Müller D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Martin Müller sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 68 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Martin Müller is affiliated with the German Cancer Research Center in Germany. Their research spans multiple disciplines including Medicine, Immunology and Microbiology, as well as Biochemistry, Genetics and Molecular Biology. This interdisciplinary approach reflects a broad engagement with both clinical and molecular aspects of disease and immune response.

The subfields of study prominently featured in their work include Epidemiology, Immunology, Molecular Biology, Genetics, and Animal Science and Zoology. These areas provide a foundation for their research into infectious diseases, immune mechanisms, and genetic factors influencing health outcomes.

The scientist's primary research topics encompass Cervical Cancer and HPV Research, Immunotherapy and Immune Responses, Hepatitis B Virus Studies, the role of interferon in immune responses, Virus-based gene therapy research, Herpesvirus Infections and Treatments, and Animal Virus Infections Studies. These focal points suggest a strong emphasis on viral pathogens and immune modulation.

Frequent publication venues for Martin Müller include Frontiers in Immunology, npj Vaccines, Vaccine, bioRxiv (Cold Spring Harbor Laboratory), and Cell Reports. These journals underscore the scientist's active contribution to immunology and vaccine research communities.

Martin Müller's frequent co-authors are:

  • Filipe Colaço Mariz
  • Peter Sehr
  • Tim Waterboer
  • Simone Ottonello
  • Xueer Zhao

Their recent papers include:

  • Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination (2022), published in Vaccine
  • Pre-arrayed Pan-AAV Peptide Display Libraries for Rapid Single-Round Screening (2020), published in Molecular Therapy
  • Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials (2021), published in The Lancet Infectious Diseases
  • Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines (2020), published in npj Vaccines
  • Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines (2020), published in Vaccine

Best Publications

  • Carrageenan Is a Potent Inhibitor of Papillomavirus Infection

    Christopher B Buck;Cynthia D Thompson;Jeffrey N Roberts;Martin Müller

  • Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

    Susanne Saussele;Johan Richter;Joelle Guilhot;Franz X Gruber

  • Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial

    Jorge E. Cortes;Dong Wook Kim;Javier Pinilla-Ibarz;Philipp D. le Coutre

  • Bcr-Abl kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet

    Simona Soverini;Andreas Hochhaus;Franck E. Nicolini;Franz Gruber

  • Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia

    Rüdiger Hehlmann;Michael Lauseker;Susanne Jung-Munkwitz;Armin Leitner

  • Impact of Baseline BCR-ABL Mutations on Response to Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase

    Timothy Hughes;Giuseppe Saglio;Susan Branford;Simona Soverini

  • Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV

    Rüdiger Hehlmann;Martin C. Müller;Michael Lauseker;Benjamin Hanfstein

  • Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV

    Alice Fabarius;Armin Leitner;Andreas Hochhaus;Martin C. Müller

  • Chimeric Papillomavirus-like Particles

    Martin Müller;Jian Zhou;Tracey D Reed;Claudia Rittmüller

  • Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study

    Rengaswamy Sankaranarayanan;Priya Ramesh Prabhu;Michael Pawlita;Tarik Gheit

  • Sustained molecular response with interferon alfa maintenance after induction therapy with imatinib plus interferon alfa in patients with chronic myeloid leukemia.

    Andreas Burchert;Martin C. Müller;Philippe Kostrewa;Philipp Erben

  • Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques

    Christiane Stahl-Hennig;Martin Eisenblätter;Edith Jasny;Tamara Rzehak

  • Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection.

    Klaus Schäfer;Martin Müller;Stefan Faath;Annette Henn

  • HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase

    Peter Sehr;Martin Müller;Reinhard Höpfl;Andreas Widschwendter

  • Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML Study IV

    Susanne Saußele;Marie-Paloma Krauß;Rüdiger Hehlmann;Michael Lauseker

  • The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis

    Philipp Erben;Juliana Schwaab;Georgia Metzgeroth;Hans-Peter Horny

  • Interferon-α, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia

    Andreas Burchert;Stefan Wölfl;Manuel Schmidt;Cornelia Brendel

  • Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinib

    Thomas Ernst;Philipp Erben;Martin C Müller;Peter Paschka

  • Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells.

    Elisabeth Bolton-Gillespie;Mirle Schemionek;Hans-Ulrich Klein;Sylwia Flis

  • Next generation prophylactic human papillomavirus vaccines

    John T Schiller;Martin Müller

Frequent Co-Authors

Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
Lutz Gissmann
Lutz Gissmann German Cancer Research Center
Timothy P. Hughes
Timothy P. Hughes South Australian Health and Medical Research Institute
Jorge E. Cortes
Jorge E. Cortes Augusta University
Neil P. Shah
Neil P. Shah University of California, San Francisco
Moshe Talpaz
Moshe Talpaz University of Michigan–Ann Arbor
Simone Ottonello
Simone Ottonello University of Parma
Francois Guilhot
Francois Guilhot Grenoble Alpes University
Michele Baccarani
Michele Baccarani University of Bologna
Victor M. Rivera
Victor M. Rivera Takeda (Japan)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees offers flexible pathways for students interested in Biology, Biochemistry, and related fields. A popular option is pursuing online biology programs, which let you study remotely and at your own pace while preparing for careers in research, healthcare, or education.

For those looking to enter allied health professions quickly, programs such as ma to lpn bridge programs online can help medical assistants transition efficiently to become licensed practical nurses. Similarly, earning an online asn program opens opportunities in nursing, offering foundational knowledge and hands-on skills required in clinical settings.

Interest in health and wellness careers also continues to rise. An online degree in nutrition prepares graduates for roles in dietetics, public health, and research, blending scientific understanding with practical application.

Online learning makes it easier than ever to start or advance your career in science and health-related fields, fitting study around your life, and enabling you to gain accredited qualifications from wherever you are.

Best Scientists Citing Martin Müller

Trending Scientists

Recently Published Articles